What's in Mitotech, SA's pipeline?

Mitotech, SA has 4 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Mitotech, SA's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mitotech-sa.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

Mitotech, SA — Portfolio Competitive Intelligence Brief

Mitotech, SA pipeline: 0 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Low Dose - SkQ1	Low Dose - SkQ1	phase 3	Mitochondria-targeted antioxidant	Mitochondrial reactive oxygen species (ROS)	Ophthalmology; Age-related degenerative diseases
High dose - SkQ1	High dose - SkQ1	phase 3	Mitochondrial-targeted antioxidant	Mitochondrial electron transport chain / reactive oxygen species	Ophthalmology; Age-related degenerative diseases
SkQ1 Ophthalmic Solution	SkQ1 Ophthalmic Solution	phase 3	Mitochondrially-targeted antioxidant	Mitochondrial electron transport chain	Ophthalmology
SkQ1 Vehicle Solution	SkQ1 Vehicle Solution	phase 3	Mitochondrially-targeted antioxidant	Mitochondrial targeting sequence	Ophthalmology, Cardiology

Therapeutic area mix

Ophthalmology; Age-related degenerative diseases · 2
Ophthalmology · 1
Ophthalmology, Cardiology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Mitotech, SA:

Cite this brief

Drug Landscape (2026). Mitotech, SA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mitotech-sa. Accessed 2026-05-15.